4.8 Article

Allele-Specific Isothermal Amplification Method Using Unmodified Self-Stabilizing Competitive Primers

Journal

ANALYTICAL CHEMISTRY
Volume 90, Issue 20, Pages 11972-11980

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acs.analchem.8b02416

Keywords

-

Funding

  1. EPSRC HiPEDS CDT [EP/L016796/1]
  2. Medical Research Council (MRC)
  3. National Science Technology Development Agency (NSTDA) of Thailand [MR/N012275/1]
  4. Wellcome Investigator Award [100993/Z/13/Z]
  5. EPSRC Global Challenge Research Fund [EP/P510798/1]
  6. TRAC
  7. Wellcome Trust [100993/Z/13/Z] Funding Source: Wellcome Trust
  8. MRC [MR/N012275/1] Funding Source: UKRI

Ask authors/readers for more resources

Rapid and specific detection of single nucleotide polymorphisms (SNPs) related to drug resistance in infectious diseases is crucial for accurate prognostics, therapeutics and disease management at point-of-care. Here, we present a novel amplification method and provide universal guidelines for the detection of SNPs at isothermal conditions. This method, called USS-sbLAMP, consists of SNP-based loop-mediated isothermal amplification (sbLAMP) primers and unmodified self-stabilizing (USS) competitive primers that robustly delay or prevent unspecific amplification. Both sets of primers are incorporated into the same reaction mixture, but always targeting different alleles; one set specific to the wild type allele and the other to the mutant allele. The mechanism of action relies on thermodynamically favored hybridization of totally complementary primers, enabling allele-specific amplification. We successfully validate our method by detecting SNPs, C580Y and Y493H, in the Plasmodium falciparum kelch 13 gene that are responsible for resistance to artemisinin-based combination therapies currently used globally in the treatment of malaria. USS-sbLAMP primers can efficiently discriminate between SNPs with high sensitivity (limit of detection of 5 x 10(1) copies per reaction), efficiency, specificity and rapidness (<35 min) with the capability of quantitative measurements for point-of-care diagnosis, treatment guidance, and epidemiological reporting of drug-resistance.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available